Public biotech in 2014--the numbers.

作者： Chris Morrison , Riku Lähteenmäki

关键词:

摘要: 2014 was another banner year for public companies, building on the strength of 2013 and adding to unprecedented biotech bull run.

参考文章(2)

Troyen A Brennan, James M Wilson, The special case of gene therapy pricing. Nature Biotechnology. ,vol. 32, pp. 874- 876 ,(2014) , 10.1038/NBT.3003

Samuel G. Jacobson, Artur V. Cideciyan, Alejandro J. Roman, Alexander Sumaroka, Sharon B. Schwartz, Elise Heon, William W. Hauswirth, Improvement and decline in vision with gene therapy in childhood blindness. The New England Journal of Medicine. ,vol. 372, pp. 1920- 1926 ,(2015) , 10.1056/NEJMOA1412965